CPTCF (Cytophage Technologies) Common Stock: $19.74 Mil (As of Dec. 2025)


CPTCF Cytophage Technologies Ltd CPTCF
18 GF Score
Price $0.21
! 1 Warning Sign
View Full Analysis

What is Cytophage Technologies Common Stock?

Cytophage Technologies CPTCF 18 Common Stock is $19.74 Mil as of Dec. 2025. GuruFocus rates CPTCF with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Cytophage Technologies's quarterly common stock declined from Jun. 2025 ($19.17 Mil) to Sep. 2025 ($18.94 Mil) but then increased from Sep. 2025 ($18.94 Mil) to Dec. 2025 ($19.74 Mil).

Cytophage Technologies's annual common stock increased from Dec. 2023 ($12.06 Mil) to Dec. 2024 ($17.75 Mil) and increased from Dec. 2024 ($17.75 Mil) to Dec. 2025 ($19.74 Mil).

Cytophage Technologies Common Stock Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Common Stock Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
11.18 11.37 12.06 17.75 19.74

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.75 17.61 19.17 18.94 19.74
CPTCF
18GF Score
Cytophage Technologies Ltd CPTCF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cytophage Technologies Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $19.74 Mil mean?
Cytophage Technologies (CPTCF) has a Common Stock of $19.74 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cytophage Technologies and its competitors.
Is Cytophage Technologies' Common Stock too high?
Cytophage Technologies' current Common Stock is $19.74 Mil. Overall, Cytophage Technologies has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Cytophage Technologies' Common Stock compare to VRTX and REGN?
Cytophage Technologies' Common Stock of $19.74 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Cytophage Technologies and its competitors. Cytophage Technologies's current Common Stock is $19.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (CPTCF) has a current Common Stock of $19.74 Mil. The current Common Stock is $19.74 Mil. Cytophage Technologies' overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Cytophage Technologies (CPTCF), the current Common Stock is $19.74 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Other Exchanges CYTO.H:Canada
Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.
18GF Score

Get the complete analysis for CPTCF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price